ArticleFrontiers in oncology2026
Case Report: A diagnostic pitfall of diffuse large B-cell lymphoma with hemophagocytic lymphohistiocytosis and atypical tongue pain: the critical role of PET/CT-guided repeat bone marrow biopsy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diffuse large B-cell lymphoma (DLBCL) associated hemophagocytic lymphohistiocytosis (HLH) represents a rare but life-threatening clinical entity characterized by diagnostic complexity and high mortality. Early manifestations are often nonspecific, and initial bone marrow examination may be falsely negative due to patchy infiltration, leading to delayed recognition of the underlying malignancy. Case presentation: We report a 68-year-old woman who presented with prolonged fever and atypical tongue pain, initially suspected to be caused by pulmonary infection. Despite broad-spectrum antimicrobial therapy, fever persisted and progressive cytopenias, hyperferritinemia, hypofibrinogenemia, and elevated soluble interleukin-2 receptor levels fulfilled the HLH-2004 diagnostic criteria. Although corticosteroid therapy achieved transient clinical improvement, the initial bone marrow biopsy revealed no malignancy. Following relapse of fever after steroid withdrawal, positron emission tomography-computed tomography (PET/CT) demonstrated diffuse hypermetabolic activity in the spleen and bone marrow. PET/CT-guided repeat bone marrow biopsy subsequently confirmed non-germinal center B-cell-type DLBCL with marrow involvement. The patient achieved clinical remission after initiation of immunochemotherapy. Conclusion: This case highlights HLH as a major diagnostic blind spot in occult B-cell lymphoma and underscores the limitations of single-site bone marrow biopsy. Persistent atypical extranodal symptoms such as tongue pain, together with steroid-responsive HLH, should prompt early functional imaging. PET/CT-guided repeat tissue sampling plays a pivotal role in establishing timely diagnosis and guiding therapeutic decisions in critically ill patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.